These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10478760)

  • 1. Increased F-18 fluorodeoxyglucose thyroidal uptake in Graves' disease.
    Santiago JF; Jana S; El-Zeftawy H; Naddaf S; Abdel-Dayem HM
    Clin Nucl Med; 1999 Sep; 24(9):714-5. PubMed ID: 10478760
    [No Abstract]   [Full Text] [Related]  

  • 2. [F-qi-FDG PET of the thyroid gland in Graves' disease].
    Börner AR; Voth E; Wienhard K; Wagner R; Schicha H
    Nuklearmedizin; 1998; 37(7):227-33. PubMed ID: 9830612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic trinity: Graves' disease on F-18 FDG PET.
    Chen YK; Wang YF; Chiu JS
    Clin Nucl Med; 2007 Oct; 32(10):816-7. PubMed ID: 17885368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of Graves' disease with presentation of unilateral diffuse uptake of radioisotopes.
    Sakata S; Fuwa Y; Goto S; Fukui M; Yuasa H; Takuno H; Sarui H; Matsui I; Ogawa T; Sasano N
    J Endocrinol Invest; 1993 Dec; 16(11):903-7. PubMed ID: 8144868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous transition of an autonomously functioning thyroid adenoma to Graves' disease.
    Bommireddipalli S; Gadiraju R; DePuey GE
    Clin Nucl Med; 2009 Dec; 34(12):845-7. PubMed ID: 20139814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated F-18 FDG uptake in the thymus in Graves' disease.
    Chen YK; Chen YL
    Clin Nucl Med; 2003 Feb; 28(2):142-3. PubMed ID: 12544139
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased uptake of technetium-99m HDP in the subcortical area of both femurs in a patient with Graves' disease.
    Bisschop PH; Adam JA; Wiersinga WM
    Thyroid; 2007 Jul; 17(7):689-90. PubMed ID: 17696842
    [No Abstract]   [Full Text] [Related]  

  • 8. Serendipitous detection of thyroid carcinoma in a patient with Graves' disease.
    Ahmad M; Johns W; Gupta SM
    Clin Nucl Med; 1999 Jan; 24(1):76. PubMed ID: 9890508
    [No Abstract]   [Full Text] [Related]  

  • 9. Graves' disease and concurrent thyroid carcinoma. The importance of thyroid scintigraphy in Graves' disease.
    Joseph UA; Jhingran SG
    Clin Nucl Med; 1995 May; 20(5):416-8. PubMed ID: 7628144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
    Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thyroid gland hemiagenesis with Graves' disease].
    Mikosch P; Gallowitsch HJ; Kresnik E; Lind P
    Nuklearmedizin; 1999; 38(1):35-7. PubMed ID: 9987780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves' disease for evaluation of active inflammation.
    Uslu-Beşli L; Kabasakal L; Sağer S; Cicik E; Asa S; Sönmezoğlu K
    Nucl Med Commun; 2017 Nov; 38(11):964-970. PubMed ID: 28863123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculation of therapeutic activity of radioiodine in Graves' disease by means of Marinelli's formula, using technetium (
    Szumowski P; Mojsak M; Abdelrazek S; Sykała M; Amelian-Fiłonowicz A; Jurgilewicz D; Myśliwiec J
    Endocrine; 2016 Dec; 54(3):751-756. PubMed ID: 27553050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose metabolism of the thyroid in Graves' disease measured by F-18-fluoro-deoxyglucose positron emission tomography.
    Boerner AR; Voth E; Theissen P; Wienhard K; Wagner R; Schicha H
    Thyroid; 1998 Sep; 8(9):765-72. PubMed ID: 9777746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical exacerbation of preexisting Graves' disease induced by insufficient radioiodine treatment: a report of five patients.
    Lee SW; Lee J; Bae JH; Seo JH; Kang SM; Ahn BC; Lee I
    Nucl Med Commun; 2009 Apr; 30(4):275-80. PubMed ID: 19252454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Simultaneous occurrence of Graves' ophthalmopathy and autonomous thyroid nodules].
    Smolarz K; Dederichs B; Schicha H
    Nuklearmedizin; 1998; 37(6):213-7. PubMed ID: 9770716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The radioiodine turnover rate as a determinant of radioiodine treatment outcome in Graves' disease.
    van Isselt JW; Broekhuizen-de Gast HS
    Hell J Nucl Med; 2010; 13(1):2-5. PubMed ID: 20411161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two unusual cases of Graves' hyperthyroidism with unilaterally increased 99mTc uptake.
    Decallonne B; Vanderstappen H; Thijs M
    Acta Clin Belg; 2012; 67(4):306-7. PubMed ID: 23019811
    [No Abstract]   [Full Text] [Related]  

  • 19. Radioiodine associated de novo Graves' opthalmopathy in an Asian cohort.
    Tay WL; Tong AKT; Hui KYD; Tang YLC; Chng CL
    Hell J Nucl Med; 2017; 20(3):227-231. PubMed ID: 29177260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased bone alkaline phosphatase and isolated subcortical bone uptake of technetium-99m hydroxymethylene diphosphonate in the lower extremities in a patient with Graves' disease: a distinctly unusual variant of Graves' acropachy.
    Ogrin C
    Thyroid; 2008 Nov; 18(11):1227-9. PubMed ID: 19014329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.